Pharmacological characterisation of the rat brachial plexus avulsion model of neuropathic pain

Brain Research

Volumn 1018, Issue 2, 2004, Pages 159-170

  Rodrigues Filho, Rubens ^a   Campos, Maria Martha ^a   Ferreira, Juliano ^a   Santos, Adair R S ^a   Bertelli, Jayme A ^b   Calixto, João B ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

Author keywords

Analgesic drug; Mechanical allodynia and Cold allodynia; Neuropathic pain; Rat brachial plexus avulsion

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; CELECOXIB; CLONIDINE; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; DICLOFENAC; GABAPENTIN; IMIPRAMINE; KETAMINE; LIDOCAINE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; SODIUM CHANNEL BLOCKING AGENT; STEROID;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AVULSION INJURY; BRACHIAL PLEXUS; COLD; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; MALE; NERVE INJURY; NEUROPATHIC PAIN; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE;

ACETIC ACIDS; AMINES; ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; BRACHIAL PLEXUS; BRACHIAL PLEXUS NEUROPATHIES; CLONIDINE; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; GAMMA-AMINOBUTYRIC ACID; KETAMINE; LIDOCAINE; MALE; MORPHINE; NEURALGIA; NOCICEPTORS; PAIN MEASUREMENT; PAIN THRESHOLD; PYRAZOLES; RADICULOPATHY; RATS; RATS, WISTAR; SULFONAMIDES;

EID: 3342931286     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.05.058     Document Type: Article

References (91)

1. Abdi S., Lee D.H., Chung J.M. The anti-allodynic effect of amitriptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesth. Analg. 87:1998;1360-1366
2. Aley K.O., Levine J.D. Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat. Neuroscience. 111:2002;389-397
3. Anand P., Birch R. Restoration of sensory function and lack of long-term chronic pain syndromes after brachial plexus injury in human. Brain. 125:2002;113-122
4. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23
5. Arner S., Lindblom U., Meyerson B.A., Molander C. Prolonged relief of neuralgia after regional anesthetic blocks. A call for further experimental and systematic clinical studies. Pain. 43:1990;287-297
6. Attal N. Chronic neuropathic pain: mechanisms and treatment. Clin. J. Pain. 16:2000;S118-S130
7. Backonja M., Arndt G., Gombar K.A., Check B., Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain. 56:1994;51-57
8. Backonja M.M., Miletic G., Miletic V. The effect of continuous morphine analgesia on chronic thermal hyperalgesia due to sciatic constriction injury in rats. Neurosci. Lett. 196:1995;61-64
9. + channels in pain pathways. Trends Pharmacol. Sci. 22:2001;27-31
10. Begon S., Pickering G., Eschalier A., Dubray C. Magnesium increases morphine analgesic effect in different experimental models of pain. Anesthesiology. 96:2002;627-632
11. Bennett G.J. An animal model of neuropathic pain: a review. Muscle Nerve. 16:1993;1040-1048
12. Bennett G.J. Animal models of neuropathic pain. Gebbart G.F., Hammond D.L., Jensen T.L. Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management Seattle. 1994;495-510 IASP Press, WA
13. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107
14. Berman J.S., Birch R., Anand P. Pain following human brachial plexus injury with spinal cord root avulsion and the effect of surgery. Pain. 75:1998;199-207
15. Beydoun A., Backonja M.M. Mechanistic stratification of antineuralgic agents. J. Pain Symptom Manag. 25:2003;58
16. Bian D., Nichols M.L., Ossipov M.H., Lai J.f, Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. NeuroReport. 6:1995;1981-1984
17. Bortalanza L.B., Ferreira J., Hess S.C., Monache F.D., Yunes R.A., Calixto J.B. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur. J. Pharmacol. 453:2002;203-208
18. Carvalho G.A., Nikkhah G., Samii M. Pain management after post-traumatic brachial plexus lesions. Conservative and surgical therapy possibilities. Orthopade. 26:1997;621-625
19. Catheline G., Le Guen S., Besson J.M. Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat: a Fos study. Pain. 92:2001;389-398
20. Chaplan S.R., Bach F.W., Shafer S.L., Yaksh T.L. Prolonged alleviation of tactile allodynia by intravenous lidocaine in neuropathic rats. Anesthesiology. 83:1995;775-785
21. Choi Y., Yoon Y.W., Na H.S., Kim S.H., Chung J.M. Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain. Pain. 59:1994;369-376
22. Christensen D., Gautron M., Guilbaud G., Kayer V. Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain. 93:2001;147-153
23. Clatworthy A.L., Illich P.A., Castro G.A., Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184:1995;5-8
24. Coombs D.W., Twitchell B.B., Deleo J.A., Colbun R.W. Amitriptyline in a mononeuropathy model: pre-lesion allodynic prophylaxis vs. acute post allodynia dose response. Reg. Anesth. 20:1995;S127
25. Courteix C., Bardin M., Chantelauze C., Lavarenne J., Eschalier A. Study of the sensitivity of the diabetes-induced pain model in rats to a range of analgesics. Pain. 57:1994;153-160
26. Dejard A., Petersen P., Kastrup J. Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet. 1:1988;9-11
27. di Vadi P.P., Hamann W. The use of lamotrigine in neuropathic pain. Anaesthesia. 53:1998;808-809
28. Dickenson A.H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol. Sci. 11:1990;307-309
29. Dickenson A.H. Neurophysiology of opioid poorly responsive pain. Cancer Surv. 21:1994;5-16
30. Eglen R.M., Hunter J.C., Dray A. Ions in the fire: recent ion-channel research and approaches to pain therapy. Trends Pharmacol. Sci. 20:1999;337-342
31. Eide P.K., Jorum E., Stubhaug A., Bremnes J., Breivik H. Relief of post-herpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: a double-blind, cross-over comparison with morphine and placebo. Pain. 58:1994;347-354
32. England J.D., Happel L.T., Kline D.G., Gamboni F., Thouron C.L., Liu Z.P., Levinson S.R. Sodium channel accumulation in humans with painful neuromas. Neurology. 47:1996;272-276
33. Erichsen H.K., Blackburn-Munro G. Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain. 98:2002;151-161
34. + channel blockers in two rat models of neuropathic pain. Eur. J. Pharmacol. 458:2003;275-282
35. Felsby S., Nielsen J., Arendt-Nielsen L., Jensen T.S. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. Pain. 64:1996;283-291
36. Fox A., Eastwood C., Centry C., Manning D., Urban L. Critical evaluation of the streptozotocin in model of painful diabetic neuropathy in the rat. Pain. 81:1999;307-316
37. Fundytus M.E. Glutamate receptors and nociception: implications for the drug treatment of pain. CNS Drugs. 15:2001;29-58
38. Galer B.S. Neuropathic pain of peripheral origin: advances in pharmacologic treatment. Neurology. 45:1995;S17-S25
39. Gazelius B., Cui J.G., Svensson M., Meyerson B., Linderoth B. Photochemically induced ischaemic lesion of the rat sciatic nerve. A novel method providing high incidence of mononeuropathy. NeuroReport. 7:1996;2619-2623
40. 2δ subunit of calcium channel. J. Biol. Chem. 271:1996;5768-5776
41. Gillin S., Sorkin L.S. Gabapentin reverses the allodynia produced by the administration of anti-GD2 ganglioside, an immunotherapeutic drug. Anesth. Analg. 86:1998;111-116
42. Hao J.X., Yu W., Xu X.J., Weisenfeld-Hallin Z. Effects of intrathecal vs. systemic clonidine in treating chronic allodynia-like response in spinally injured rats. Brain Res. 736:1996;28-34
43. Hao J.-X., Xu X.-J., Urban L., Hallin-Wiesenfeld Z. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci. Lett. 280:2000;211-214
44. Hunter J.C., Gogas K.R., Hedley L.R., Jacobsen L.O., Kassotakis L., Thompson I., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur. J. Pharmacol. 324:1997;153-160
45. Idänpään-Heikkilä J.J., Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen, but not carbamazepine, morphine or tricyclic antidepressants, attenuates the allodynia-like behaviour. Pain. 79:1999;281-290
46. Jett M.-F., McGuirk J., Waligora D., Hunter J.C. The effects of mexiletine, desipramine and fluoxetine in rat models involving central sensitization. Pain. 69:1997;161-169
47. Jevtovic-Todorovic V., Wozniak D.F., Powell S., Nardi A., Olney J.W. Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects. Brain Res. 781:1998;202-211
48. Kim S.H., Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363
49. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139
50. 2 adrenergic agonist, dexmedetomidine, in the spinal nerve ligation model of neuropathic pain. Anesth. Analg. 86:1998;355-360
51. Lashbrook J.M., Ossipov M.H., Hunter J.C., Raffa R.B., Tallarida R.J., Porreca F. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX-1 and COX-2 inhibitors in nerve injured rats. Pain. 82:1999;65-72
52. Lee Y.W., Chaplan S.R., Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 199:1995;111-114
53. Lindstrom P., Lindblom U. The analgesic effect of tocadine in trigeminal neuralgia. Pain. 28:1987;45-50
54. Ma W.Y., Du W., Eisenach J.C. Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res. 937(1-2):2002;94-99
55. Mao J., Chen L.L. Systemic lidocaine for neuropathic pain relief. Pain. 87:2000;7-17
56. Mao J., Price D.D., Hayes R.L., Lu J., Mayer D.J., Frenk H. Intrathecal treatment with dextrorphan or ketamine potently reduces pain-related behaviors in a rat model of peripheral mononeuropathy. Brain Res. 605:1993;164-168
57. Max M.B., Byas-Smith M.G., Gracely R.H., Bennett G.J. Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo. Clin. Neuropharmacol. 18:1995;360-368
58. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. BMJ. 311:1995;1047-1052
59. Mercadante S., Lodi F., Sapio M., Calligara M., Serretta R. Long-term ketamine subcutaneous continuous infusion in neuropathic cancer pain. J. Pain Symptom Manage. 10:1995;564-568
60. Nikolajsen L., Hansen C.L., Nielsen J., Keller J., Arendt-Nielsen L., Jensen T.S. The effect of ketamine on phantom pain: a central neuropathic disorder maintained by peripheral input. Pain. 67:1996;69-77
61. + channel distribution in the nervous system. Trends Neurosci. 24:2001;473-478
62. Nurmikko T.J., Nash T.P., Wiles J.R. Recent advances: control of chronic pain. BMJ. 317:1998;1438-1441
63. Pan H.L., Eisenach J.C., Chen S.R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J. Pharmacol. Exp. Ther. 288:1999;1026-1030
64. Payne R. Neuropathic pain syndromes with special reference to causalgia and reflex sympathetic dystrophy. Clin. J. Pain. 2:1986;59-73
65. Pertovaara A., Wei H. A dissociative change in the efficacy of supraspinal versus spinal morphine in the neuropathic rat. Pain. 101:2003;237-250
66. Pinheiro R.M., Calixto J.B. Effects of the selective COX-2 inhibitors, celecoxib and rofecoxib in rat acute models of inflammation. Inflamm. Res. 51:2002;603-610
67. Priest T.D., Hoggart B. Chronic pain: mechanisms and treatment. Curr. Opin. Pharmacol. 2:2002;310-315
68. Qian J., Brown S.D., Carlton S.M. Systemic ketamine attenuates nociceptive behaviours in a rat model of peripheral neuropathy. Brain Res. 715:1996;51-62
69. Randall L.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111:1957;409-419
70. Rodrigues-Filho R., Santos A.R.S., Bertelli J.A., Calixto J.B. Avulsion injury of the brachial plexus triggers hyperalgesia and allodynia in the hindpaws: a new model for the study of neuropathic pain. Brain Res. 982:2003;186-194
71. Sah D.W.Y., Ossipov M.H., Porreca F. Neurotrophic factors as novel therapeutics for neuropathic pain. Nat. Rev. 2:2003;460-472
72. Seltzer Z., Tal M., Sharav Y. Autotomy behavior in rats following peripheral deafferentation is suppressed by daily injections of amitriptyline, diazepam and saline. Pain. 37:1989;245-250
73. Seltzer Z., Dubner R., Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218
74. Shimizu T., Shibata M., Wakisaka S., Takaya I., Mashimo T., Yoshiya I. Intrathecal lithium reduces neuropathic pain responses in a rat model of peripheral neuropathy. Pain. 85:2000;59-64
75. Sindrup H.S., Jensen S.T. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400
76. Sonoda H., Omote K. Suppressive effects of ketamine on neuropathic pain. Masui. 47:1998;136-144
77. Spruce M.C., Potter J., Coppini D.V. The pathogenesis and management of painful diabetic neuropathy: a review. Diabet. Med. 20:2003;88-98
78. Syriatowicz J.P., Hu D., Walker J.S., Tracey D.J. Hyperalgesia due to nerve injury: role of prostaglandins. Neuroscience. 94:1999;587-594
79. Taiwo Y.O., Coderre T.J., Levine J.D. The contribution of training to sensitivity in the nociceptive paw-withdrawal test. Brain Res. 487:1989;148-151
80. Takasaki I., Andoh T., Nita M., Takahata H., Nemoto H., Shiraki K., Nojima H., Kuraishi Y. Pharmacological and immunohistochemical characterization of a mouse model of acute herpetic pain. Jpn. Pharm. 83:2000;319-326
81. 2-adrenoreceptors on post-ganglionic sympathetic terminals. Pain. 60:1995;317-327
82. Yokogawa F., Kiuchi Y., Ishikawa Y., Otsuka N., Masuda Y., Oguchi K., Hosoyamada A. An investigation of monoamine receptors involved in antinociceptive effects of antidepressants. Anesth. Analg. 95:2002;163-168
83. Wallace M.S., Ridgeway B.M., Leung A.Y., Gerayli A., Yaksh T.L. Concentration-effect relationship of intravenous lidocaine on the allodynia of complex regional pain syndrome types I and II. Anesthesiology. 92:2000;75-83
84. Wang Y.-X., Bowersox S.S., Pettus M., Gao D. Antinociceptive properties of fenfluramine, a serotonin reuptake inhibitor, in a rat model of neuropathy. J. Pharmacol. Exp. Ther. 291:1999;1008-1116
85. Waxman S.G., Dib-Hajj S., Cummins T.R., Black J.A. Sodium channel and pain. Proc. Natl. Acad. Sci. U. S. A. 96:1999;7635-7639
86. Parry C.B.W. Pain in avulsion lesions of the brachial plexus. Pain. 9:1980;41-53
87. Parry C.B.W. Pain in avulsion of the brachial plexus. Neurosurgery. 15:1984;960-964
88. Zanini M., Takahashi R.N. Sex difference in sensitization to the locomotor effects of mazindol in rats. Brain Res. Bull. 34:1994;385-387
89. Zhao Z., Chen S.R., Eisenach J.C., Busija D.W., Pan H.L. Spinal cyclooxigenase-2 is involved in development of allodynia after nerve injury in rats. Neuroscience. 97:2000;743-748
90. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110
91. Zimmermann M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 429:2001;23-37